|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:CASKIN2-PDE2A (FusionGDB2 ID:13251) |
Fusion Gene Summary for CASKIN2-PDE2A |
Fusion gene summary |
Fusion gene information | Fusion gene name: CASKIN2-PDE2A | Fusion gene ID: 13251 | Hgene | Tgene | Gene symbol | CASKIN2 | PDE2A | Gene ID | 57513 | 5138 |
Gene name | CASK interacting protein 2 | phosphodiesterase 2A | |
Synonyms | ANKS5B | CGS-PDE|PDE2A1|PED2A4|cGSPDE | |
Cytomap | 17q25.1 | 11q13.4 | |
Type of gene | protein-coding | protein-coding | |
Description | caskin-2 | cGMP-dependent 3',5'-cyclic phosphodiesterasecGMP-stimulated phosphodiesterase 1cGMP-stimulated phosphodiesterase 2cGMP-stimulated phosphodiesterase 4cyclic GMP-stimulated phosphodiesterasephosphodiesterase 2A, cGMP-stimulated | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q8WXE0 | . | |
Ensembl transtripts involved in fusion gene | ENST00000321617, ENST00000433559, ENST00000581870, | ENST00000334456, ENST00000376450, ENST00000444035, ENST00000544570, ENST00000418754, ENST00000540345, ENST00000540380, | |
Fusion gene scores | * DoF score | 3 X 2 X 3=18 | 11 X 7 X 7=539 |
# samples | 3 | 12 | |
** MAII score | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(12/539*10)=-2.16725086714399 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CASKIN2 [Title/Abstract] AND PDE2A [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | CASKIN2(73509792)-PDE2A(72353370), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | CASKIN2-PDE2A seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. CASKIN2-PDE2A seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. CASKIN2-PDE2A seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. CASKIN2-PDE2A seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | PDE2A | GO:0000122 | negative regulation of transcription by RNA polymerase II | 17329248 |
Tgene | PDE2A | GO:0007193 | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 17329248 |
Tgene | PDE2A | GO:0036006 | cellular response to macrophage colony-stimulating factor stimulus | 14687666 |
Tgene | PDE2A | GO:0046069 | cGMP catabolic process | 19828435 |
Tgene | PDE2A | GO:0071320 | cellular response to cAMP | 17329248 |
Tgene | PDE2A | GO:0071321 | cellular response to cGMP | 17704206|19828435 |
Tgene | PDE2A | GO:1904613 | cellular response to 2,3,7,8-tetrachlorodibenzodioxine | 17329248 |
Fusion gene breakpoints across CASKIN2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across PDE2A (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | PRAD | TCGA-YL-A8SF-01A | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
Top |
Fusion Gene ORF analysis for CASKIN2-PDE2A |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000321617 | ENST00000334456 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
In-frame | ENST00000321617 | ENST00000376450 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
Frame-shift | ENST00000321617 | ENST00000444035 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
In-frame | ENST00000321617 | ENST00000544570 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
Frame-shift | ENST00000321617 | ENST00000418754 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
Frame-shift | ENST00000321617 | ENST00000540345 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
5CDS-intron | ENST00000321617 | ENST00000540380 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
intron-3CDS | ENST00000433559 | ENST00000334456 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
intron-3CDS | ENST00000433559 | ENST00000376450 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
intron-3CDS | ENST00000433559 | ENST00000444035 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
intron-3CDS | ENST00000433559 | ENST00000544570 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
intron-3CDS | ENST00000433559 | ENST00000418754 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
intron-3CDS | ENST00000433559 | ENST00000540345 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
intron-intron | ENST00000433559 | ENST00000540380 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
Frame-shift | ENST00000581870 | ENST00000334456 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
In-frame | ENST00000581870 | ENST00000376450 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
Frame-shift | ENST00000581870 | ENST00000444035 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
In-frame | ENST00000581870 | ENST00000544570 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
Frame-shift | ENST00000581870 | ENST00000418754 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
Frame-shift | ENST00000581870 | ENST00000540345 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
5CDS-intron | ENST00000581870 | ENST00000540380 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000321617 | CASKIN2 | chr17 | 73509792 | - | ENST00000376450 | PDE2A | chr11 | 72353370 | - | 3931 | 681 | 1224 | 424 | 266 |
ENST00000321617 | CASKIN2 | chr17 | 73509792 | - | ENST00000544570 | PDE2A | chr11 | 72353370 | - | 3666 | 681 | 233 | 1009 | 258 |
ENST00000581870 | CASKIN2 | chr17 | 73509792 | - | ENST00000376450 | PDE2A | chr11 | 72353370 | - | 3788 | 538 | 1081 | 281 | 266 |
ENST00000581870 | CASKIN2 | chr17 | 73509792 | - | ENST00000544570 | PDE2A | chr11 | 72353370 | - | 3523 | 538 | 90 | 866 | 258 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000321617 | ENST00000376450 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - | 0.4645276 | 0.5354724 |
ENST00000321617 | ENST00000544570 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - | 0.19520578 | 0.80479425 |
ENST00000581870 | ENST00000376450 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - | 0.4539867 | 0.5460133 |
ENST00000581870 | ENST00000544570 | CASKIN2 | chr17 | 73509792 | - | PDE2A | chr11 | 72353370 | - | 0.1781139 | 0.82188606 |
Top |
Fusion Genomic Features for CASKIN2-PDE2A |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for CASKIN2-PDE2A |
Go to FGviewer for the breakpoints of chr17:73509792-chr11:72353370 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CASKIN2 | . |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | PDE2A | chr17:73509792 | chr11:72353370 | ENST00000334456 | 0 | 31 | 241_377 | 23.666666666666668 | 942.0 | Domain | GAF 1 | |
Tgene | PDE2A | chr17:73509792 | chr11:72353370 | ENST00000334456 | 0 | 31 | 409_548 | 23.666666666666668 | 942.0 | Domain | GAF 2 | |
Tgene | PDE2A | chr17:73509792 | chr11:72353370 | ENST00000334456 | 0 | 31 | 578_902 | 23.666666666666668 | 942.0 | Domain | PDEase | |
Tgene | PDE2A | chr17:73509792 | chr11:72353370 | ENST00000444035 | 0 | 31 | 241_377 | 14.666666666666666 | 933.0 | Domain | GAF 1 | |
Tgene | PDE2A | chr17:73509792 | chr11:72353370 | ENST00000444035 | 0 | 31 | 409_548 | 14.666666666666666 | 933.0 | Domain | GAF 2 | |
Tgene | PDE2A | chr17:73509792 | chr11:72353370 | ENST00000444035 | 0 | 31 | 578_902 | 14.666666666666666 | 933.0 | Domain | PDEase | |
Tgene | PDE2A | chr17:73509792 | chr11:72353370 | ENST00000540345 | 1 | 32 | 241_377 | 14.666666666666666 | 933.0 | Domain | GAF 1 | |
Tgene | PDE2A | chr17:73509792 | chr11:72353370 | ENST00000540345 | 1 | 32 | 409_548 | 14.666666666666666 | 933.0 | Domain | GAF 2 | |
Tgene | PDE2A | chr17:73509792 | chr11:72353370 | ENST00000540345 | 1 | 32 | 578_902 | 14.666666666666666 | 933.0 | Domain | PDEase | |
Tgene | PDE2A | chr17:73509792 | chr11:72353370 | ENST00000334456 | 0 | 31 | 656_660 | 23.666666666666668 | 942.0 | Region | Note=Substrate binding | |
Tgene | PDE2A | chr17:73509792 | chr11:72353370 | ENST00000444035 | 0 | 31 | 656_660 | 14.666666666666666 | 933.0 | Region | Note=Substrate binding | |
Tgene | PDE2A | chr17:73509792 | chr11:72353370 | ENST00000540345 | 1 | 32 | 656_660 | 14.666666666666666 | 933.0 | Region | Note=Substrate binding |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | CASKIN2 | chr17:73509792 | chr11:72353370 | ENST00000321617 | - | 2 | 20 | 685_1133 | 31.333333333333332 | 1203.0 | Compositional bias | Note=Pro-rich |
Hgene | CASKIN2 | chr17:73509792 | chr11:72353370 | ENST00000433559 | - | 1 | 19 | 685_1133 | 0 | 1121.0 | Compositional bias | Note=Pro-rich |
Hgene | CASKIN2 | chr17:73509792 | chr11:72353370 | ENST00000321617 | - | 2 | 20 | 281_347 | 31.333333333333332 | 1203.0 | Domain | SH3 |
Hgene | CASKIN2 | chr17:73509792 | chr11:72353370 | ENST00000321617 | - | 2 | 20 | 489_552 | 31.333333333333332 | 1203.0 | Domain | SAM 1 |
Hgene | CASKIN2 | chr17:73509792 | chr11:72353370 | ENST00000321617 | - | 2 | 20 | 558_622 | 31.333333333333332 | 1203.0 | Domain | SAM 2 |
Hgene | CASKIN2 | chr17:73509792 | chr11:72353370 | ENST00000433559 | - | 1 | 19 | 281_347 | 0 | 1121.0 | Domain | SH3 |
Hgene | CASKIN2 | chr17:73509792 | chr11:72353370 | ENST00000433559 | - | 1 | 19 | 489_552 | 0 | 1121.0 | Domain | SAM 1 |
Hgene | CASKIN2 | chr17:73509792 | chr11:72353370 | ENST00000433559 | - | 1 | 19 | 558_622 | 0 | 1121.0 | Domain | SAM 2 |
Hgene | CASKIN2 | chr17:73509792 | chr11:72353370 | ENST00000321617 | - | 2 | 20 | 114_143 | 31.333333333333332 | 1203.0 | Repeat | Note=ANK 3 |
Hgene | CASKIN2 | chr17:73509792 | chr11:72353370 | ENST00000321617 | - | 2 | 20 | 147_176 | 31.333333333333332 | 1203.0 | Repeat | Note=ANK 4 |
Hgene | CASKIN2 | chr17:73509792 | chr11:72353370 | ENST00000321617 | - | 2 | 20 | 188_217 | 31.333333333333332 | 1203.0 | Repeat | Note=ANK 5 |
Hgene | CASKIN2 | chr17:73509792 | chr11:72353370 | ENST00000321617 | - | 2 | 20 | 220_249 | 31.333333333333332 | 1203.0 | Repeat | Note=ANK 6 |
Hgene | CASKIN2 | chr17:73509792 | chr11:72353370 | ENST00000321617 | - | 2 | 20 | 48_77 | 31.333333333333332 | 1203.0 | Repeat | Note=ANK 1 |
Hgene | CASKIN2 | chr17:73509792 | chr11:72353370 | ENST00000321617 | - | 2 | 20 | 81_110 | 31.333333333333332 | 1203.0 | Repeat | Note=ANK 2 |
Hgene | CASKIN2 | chr17:73509792 | chr11:72353370 | ENST00000433559 | - | 1 | 19 | 114_143 | 0 | 1121.0 | Repeat | Note=ANK 3 |
Hgene | CASKIN2 | chr17:73509792 | chr11:72353370 | ENST00000433559 | - | 1 | 19 | 147_176 | 0 | 1121.0 | Repeat | Note=ANK 4 |
Hgene | CASKIN2 | chr17:73509792 | chr11:72353370 | ENST00000433559 | - | 1 | 19 | 188_217 | 0 | 1121.0 | Repeat | Note=ANK 5 |
Hgene | CASKIN2 | chr17:73509792 | chr11:72353370 | ENST00000433559 | - | 1 | 19 | 220_249 | 0 | 1121.0 | Repeat | Note=ANK 6 |
Hgene | CASKIN2 | chr17:73509792 | chr11:72353370 | ENST00000433559 | - | 1 | 19 | 48_77 | 0 | 1121.0 | Repeat | Note=ANK 1 |
Hgene | CASKIN2 | chr17:73509792 | chr11:72353370 | ENST00000433559 | - | 1 | 19 | 81_110 | 0 | 1121.0 | Repeat | Note=ANK 2 |
Top |
Fusion Gene Sequence for CASKIN2-PDE2A |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000321617_ENST00000376450_TCGA-YL-A8SF-01A_CASKIN2_chr17_73509792_-_PDE2A_chr11_72353370_length(transcript)=3931nt_BP=681nt GACGGTCCCTCCGTTCCCGATCCGGCGGGAGGGAGGGGGGAGGGGCGGGATTTCCTGCGGGAGGCGCCGAGCCGGCCTTGGAAAAGGAGA AGGAGAAAGGGGGGCAGGGGGGAGTGGGAGCCACCGTCCTGAGTGCCAGGGACCGAGCAGGGCCAGCCGGACCCCGGCGGGCGGCCGGGA GAGAGCCCTGAGACCAGTGCACCGCTGCTGCCTGAGGCCCAAGGGAATGCTGGCTGCTCTCTGGGTGGGCACTGGTGTTCCACAGCCAAG CCGGGAAGATTGGTGTGCCCAGTCCCAGCCCATCCTGGAGCTGTCGGAAGCCACAAGCTGATATCCATCCAGATTTCCATGTAGCCTTCA CCCCCTCAAAGATTAGCTTTCCTTCGTGTGGTGGCAGTTCACGGAGCACCTTTGGGAGTATCCCTCAGTACCTGACGAGGAGCCCACTGC CTGGGACACCTGACTTGCTCCCCCGGAACCGGGAGCCCTCCAAGGGGCTGTGGCATGGCGCCCTGACGCCCCAGCTTGGACCCGTTGCCT GCCTTTGCCCTGGACTCCTGAGTGTAGAGCTCAGCCCAGGAGCCAGTATGGGTCGTGAACAGGACCTGATCCTCGCCGTCAAGAATGGAG ATGTGACCGGTGTGCAGAAACTGGTGGCGAAGGTCAAGGCCACAAAGACAAGCTGTTGCAGGACCTGTTCCCCAAAGCGGCAGAGCTGTA CGAGCGCGTGGCCTCCAACCGTGAGCACTGGACCAAGGTGTCCCACAAGTTCACCATCCGCGGCCTCCCAAGTAACAACTCGCTGGACTT CCTGGATGAGGAGTACGAGGTGCCTGATCTGGATGGCACTAGGGCCCCCATCAATGGCTGCTGCAGCCTTGATGCTGAGTGATCCCCTCC AGGGACACTTCCCTGCCCAGGCCACCTCCCACAGCCCTCCACTGGTCTGGCCAGATGCACTGGGAACAGAGCCACGGGTCCTGGGTCCTA GACCAGGACTTCCTGTGTGACCCTGGACAAGTACTACCTTCCTGGGCCTCAGCTTTCTCGTCTGTATAATGGAAGCAAGACTTCCAACCT CACGGAGACTTTGTAATTTGTTTTCTGAGAGCACAGGGGTGACCAATGAGCAGTGGGCCCTACTCTGCACCTCTGACCACACCTTGGCAA GTCTTTCCCAAGCCATTCTTTGTCTGAGCAGCTTGATGGTTTCTCCTTGCCCCATTTCTGCCCCACCAGATCTTTGCTCCTTTCCCTTTG AGGACTCCCACCCTTTGGGGTCTCCAGGATCCTCATGGAAGGGGAAGGTGAGACATCTGAGTGAGCAGAGTGTGGCATCTTGGAAACAGT CCTTAGTTCTGTGGGAGGACTAGAAACAGCCGCGGGGCGAAGGCCCCCTGAGGACCACTACTATACTGATGGTGGGATTGGGACCTGGGG GATACAGGGGCCCCAGGAAGAAGCTGCCAGAGGGGCAGCTCAGTGCTCTGCAGAGAGGGGCCCTGGGGAGAAGCAGGATGGGATTGATGG GCAGGAGGGATCCCCGCACTGGGAGACAGGCCCAGGTATGAATGAGCCAGCCATGCTTCCTCCTGCCTGTGTGACGCTGGGCGAGTCTCT TCCCCTGTCTGGGCCAAACAGGGAGCGGGTAAGACAATCCATGCTCTAAGATCCATTTTAGATCAATGTCTAAAATAGCTCTATCGCTCT GCGGAGTCCCAGCAGAGGCTATGGAATGTTTCTGCAACCCTAAGGCACAGAGAGCCCAACCCTGAGTGTCTCAGAGGCCCCCTGAGTGTT CCCCTTGGCCTGAGCCCCTTACCCATTCCTGCAGCCAGTGAGAGACCTGGCCTCAGCCCTGGCAGGGCTCTCTCTTCAAGGCCATATCCA CCTGTGCCCTGGGGCTTGGGAGACCCCATAGGGCCGGGACTCTTGGGTCAGCCCGGCCACTGGCTTCTCTCTTTTTCTCTGTTTCATTCT GTGTGCGTTGTGGGGTGGGGGAGGGGGTCCACCTGCCTTACCTTTCTGAGTTGCCTTTAGAGAGATGCGTTTTTCTAGGACTCTGTGCAA CTGTCGTATATGGTCCCGTGGGCTGACCGCTTTGTACATGAGAATAAATCTATTTCTTTCTACCGAGAAGGCCATGGGCAACAGGCCGAT GGAGATGATGGACCGGGAGAAGGCCTATATCCCTGAGCTGCAAATCAGCTTCATGGAGCACATTGCAATGCCCATCTACAAGAGCTGATC TACAAAGAATTCTTCTCCCAGGGAGACCTGTGGGCTACGACCGAAACAACAAGCAGCACCACAGACTTCTCCTCTGCCTCCTCATGACCT CCTGTGACCTCTCTGACCAGACCAAGGGCTGGAAGACTACGAGAAAGATCGCGGACTATCAGCGCATGCTGGATCTGATGCGGGACATCA TCTTGGCCACAGACCTGGCCCACCATCTCCGCATCTTCAAGGACCTCCAGAAGATGGCTGAGGAGGCACCACTTTGCTCAGGCCATCGCC ATCCTCAACACCCACGGCTGCAACATCTTTGATCATTTCTCCCGGAAGAAATCTGTGCTGGCTGCGCTCTACAGCTCTGAGGGCTCCGTC ATGGAGGGACATCGAGATCTTTGCCTTGTTTATTTCCTGCATGTGTCATGACCTGGACCACAGAGGCACAAACAACTCTTTCCAGGTGGC CTCGGTTCTGTTTGATGGTGAAGAAGGGCTACCGGGATCCCCCCTACCACAACTGGATGCACGCCTTTTCTGTCTCCCACTTCTGCTACC TGCTCTACAAGAACCTGGAGCTCACCAACTACCTCGAGCCATCCTGAGCATGCTGCAGGACATGAATTTCATCAACAACTACAAAATTGA CTGCCCGACCCTGGCCCGGTCTCCGATGATGAGTATACCAAACTTCTCCATGATGGGATCCAGCCTGTGGCTGCCATTGACTCCAATTTT GCAAGTTTCACCTATACCCCTCGTTCCCTGCCCGAGGATGACACGTCCATGTCTCTCCTATACAAAAAAGTGAATGAGGCTCAGTATCGC AGCCACCTGGCCAATGAGATGATGATGTACCACATGAAGAGGTCATCGGTGTGGCCGAGCTGGTGAACAAGATCAATGGGCCATGGTTCA GCAAGTTCGACGAGGACCTGGCGACGGCCTTCTCCATCTACTGCGGCATCAGCATCGCCCATAGCTATGAGATCCGCATCCCGGCCGATC AGGGCATCGCGGGACACGTGGCGACCACGGGCCAGATCCTGAACATCCCTGACGCATATGCCCATCCGCTTTTCTACCGCGGCGTGGACG ACAGCACCGGCTTCCGCACGCGCAACATCCTCTGCTTCCCCATCAAGAACGAGAACCAGGCTGCTCTGTGTTCCTGCTGGATCAGAATGA GCTGGTGGCCAAGGTGTTCGACGGGGGCGTGGTGGATGATGAGATGACGTCTCTGTCCTGCTCCAGGAGATCATCACGGAGGCCAGAAAC CTCAGCAACGCAGAGATGCTCTTCTCCAAGTGGCAAAGAACCTCTTCACCCACCTGGGTTCACCGACGAGGACGAGCATGTGATCCAGCA CTGCTTCCACTACACCAGCACCGTGCTCACCAGCACCCTGGCCTTCCAGAAGGAACAGAAACTCAAGTGTGAGTGCCAGGAAACTGTCTA CACCTACCTACTGGATGGTGAGTCCCAGCTGGTGTGTGAGGACCCCCCACATGAGCTGCCCCAGGAGGGGAAAGTCCGGACGCCTTGCTG AGTCTGGGCTCTGTCATCGACATTTCAGGCCTGCAACGTGCTGTCAAGGAGGCCCTGTCAGCTGTGCTCCCCCGAGTGGCGGGGCCAGCA >In-frame_ENST00000321617_ENST00000376450_TCGA-YL-A8SF-01A_CASKIN2_chr17_73509792_-_PDE2A_chr11_72353370_length(amino acids)=266AA_start in transcript=1224_stop in transcript=424 MGQGETIKLLRQRMAWERLAKVWSEVQSRAHCSLVTPVLSENKLQSLREVGSLASIIQTRKLRPRKVVLVQGHTGSPGLGPRTRGSVPSA SGQTSGGLWEVAWAGKCPWRGSLSIKAAAAIDGGPSAIQIRHLVLLIQEVQRVVTWEAADGELVGHLGPVLTVGGHALVQLCRFGEQVLQ -------------------------------------------------------------- >In-frame_ENST00000321617_ENST00000544570_TCGA-YL-A8SF-01A_CASKIN2_chr17_73509792_-_PDE2A_chr11_72353370_length(transcript)=3666nt_BP=681nt GACGGTCCCTCCGTTCCCGATCCGGCGGGAGGGAGGGGGGAGGGGCGGGATTTCCTGCGGGAGGCGCCGAGCCGGCCTTGGAAAAGGAGA AGGAGAAAGGGGGGCAGGGGGGAGTGGGAGCCACCGTCCTGAGTGCCAGGGACCGAGCAGGGCCAGCCGGACCCCGGCGGGCGGCCGGGA GAGAGCCCTGAGACCAGTGCACCGCTGCTGCCTGAGGCCCAAGGGAATGCTGGCTGCTCTCTGGGTGGGCACTGGTGTTCCACAGCCAAG CCGGGAAGATTGGTGTGCCCAGTCCCAGCCCATCCTGGAGCTGTCGGAAGCCACAAGCTGATATCCATCCAGATTTCCATGTAGCCTTCA CCCCCTCAAAGATTAGCTTTCCTTCGTGTGGTGGCAGTTCACGGAGCACCTTTGGGAGTATCCCTCAGTACCTGACGAGGAGCCCACTGC CTGGGACACCTGACTTGCTCCCCCGGAACCGGGAGCCCTCCAAGGGGCTGTGGCATGGCGCCCTGACGCCCCAGCTTGGACCCGTTGCCT GCCTTTGCCCTGGACTCCTGAGTGTAGAGCTCAGCCCAGGAGCCAGTATGGGTCGTGAACAGGACCTGATCCTCGCCGTCAAGAATGGAG ATGTGACCGGTGTGCAGAAACTGGTGGCGAAGGTCAAGGCCACAAAGACAAGCTGTTGCAGGACCTGTTCCCCAAAGCGGCAGAGCTGTA CGAGCGCGTGGCCTCCAACCGTGAGCACTGGACCAAGGTGTCCCACAAGTTCACCATCCGCGGCCTCCCAAGTAACAACTCGCTGGACTT CCTGGATGAGGAGTACGAGGTGCCTGATCTGGATGGCACTAGGGCCCCCATCAATGGCTGCTGCAGCCTTGATGCTGAGTGATCCCCTCC AGGGACACTTCCCTGCCCAGGCCACCTCCCACAGCCCTCCACTGGTCTGGCCAGATGCACTGGGAACAGAGCCACGGGTCCTGGGTCCTA GACCAGGACTTCCTGTGTGACCCTGGACAAGTACTACCTTCCTGGGCCTCAGCTTTCTCGTCTGTATAATGGAAGCAAGACTTCCAACCT CACGGAGACTTTGTAATTTGTTTTCTGAGAGCACAGGGGTGAGAGAAGGCCATGGGCAACAGGCCGATGGAGATGATGGACCGGGAGAAG GCCTATATCCCTGAGCTGCAAATCAGCTTCATGGAGCACATTGCAATGCCCATCTACAAGAGCTGATCTACAAAGAATTCTTCTCCCAGG GAGACCTGTGGGCTACGACCGAAACAACAAGCAGCACCACAGACTTCTCCTCTGCCTCCTCATGACCTCCTGTGACCTCTCTGACCAGAC CAAGGGCTGGAAGACTACGAGAAAGATCGCGGACTATCAGCGCATGCTGGATCTGATGCGGGACATCATCTTGGCCACAGACCTGGCCCA CCATCTCCGCATCTTCAAGGACCTCCAGAAGATGGCTGAGGAGGCACCACTTTGCTCAGGCCATCGCCATCCTCAACACCCACGGCTGCA ACATCTTTGATCATTTCTCCCGGAAGAAATCTGTGCTGGCTGCGCTCTACAGCTCTGAGGGCTCCGTCATGGAGGGACATCGAGATCTTT GCCTTGTTTATTTCCTGCATGTGTCATGACCTGGACCACAGAGGCACAAACAACTCTTTCCAGGTGGCCTCGGTTCTGTTTGATGGTGAA GAAGGGCTACCGGGATCCCCCCTACCACAACTGGATGCACGCCTTTTCTGTCTCCCACTTCTGCTACCTGCTCTACAAGAACCTGGAGCT CACCAACTACCTCGAGCCATCCTGAGCATGCTGCAGGACATGAATTTCATCAACAACTACAAAATTGACTGCCCGACCCTGGCCCGGTCT CCGATGATGAGTATACCAAACTTCTCCATGATGGGATCCAGCCTGTGGCTGCCATTGACTCCAATTTTGCAAGTTTCACCTATACCCCTC GTTCCCTGCCCGAGGATGACACGTCCATGTCTCTCCTATACAAAAAAGTGAATGAGGCTCAGTATCGCAGCCACCTGGCCAATGAGATGA TGATGTACCACATGAAGAGGTCATCGGTGTGGCCGAGCTGGTGAACAAGATCAATGGGCCATGGTTCAGCAAGTTCGACGAGGACCTGGC GACGGCCTTCTCCATCTACTGCGGCATCAGCATCGCCCATAGCTATGAGATCCGCATCCCGGCCGATCAGGGCATCGCGGGACACGTGGC GACCACGGGCCAGATCCTGAACATCCCTGACGCATATGCCCATCCGCTTTTCTACCGCGGCGTGGACGACAGCACCGGCTTCCGCACGCG CAACATCCTCTGCTTCCCCATCAAGAACGAGAACCAGGCTGCTCTGTGTTCCTGCTGGATCAGAATGAGCTGGTGGCCAAGGTGTTCGAC GGGGGCGTGGTGGATGATGAGATGACGTCTCTGTCCTGCTCCAGGAGATCATCACGGAGGCCAGAAACCTCAGCAACGCAGAGATGCTCT TCTCCAAGTGGCAAAGAACCTCTTCACCCACCTGGGTTCACCGACGAGGACGAGCATGTGATCCAGCACTGCTTCCACTACACCAGCACC GTGCTCACCAGCACCCTGGCCTTCCAGAAGGAACAGAAACTCAAGTGTGAGTGCCAGGAGGATGTACAACAGCTGCAGAGCATGTTGGGC TGTGAGCTGCAGGCCATGCTCTGTGTCCCTGTCATCAGCCGGGCCACTGACCAGGTGGTGGCCTTGGCCTGCGCCTTCAACAAGCTAGAA GGAGACTTTTGACAGGATGCCTGGGCCAGGTGGTGGAAGACAAGAAGTCCATCCAGCTGAAGGACCTCACCTCCGTCATCGGAGACAAAG TGCTCGGGGAAGAGGTCAGCTTTCCCCTGCAGCAGGAGACCCGGGCATCCCGCTGCTGCCTCCTGCTGGTGTCGGAGGACAATCTCCAGC TTTCTTGCAAGGGGAACTCTACGACCTGGATGCCTCTTCCCTGCAGCTCAAAGTGCTCCAATACACCCTGGTCGCCCTGCGGAGGGTGCA GGTCCTGCAGCAGCGCGGGCCCAGGGAGGCTCCCCGAGCCGTCCAGAACCCCCCGGAGGGGACGGCGGAAGACCAGAAGGGCGGGGCGGC GTACACCGACCGCGACCGCAAGATCCTCCAACTGTGCGGTGCACTGTGGCCAGCTGAGTGATAATGAGGAATGGAGCCTGCAGGCGGTGG AGAAGCATTGCTGGTCATGCCGCTAGCGGACAAGGAGGCTGGGGCCGTGGCAGCTGTCATCTTGGGAGGCTATCATCTCCCAGAAGCGGC TGGGCTGCAATGGGCTGGGCTTCTCAGACCTGCCAGGGAAGCCCTTGGCCAGGCTGGTGGCTCCACTGGCTCCTGATACCCAAGGAAACT GTCTACACCTACCTACTGGATGGTGAGTCCCAGCTGGTGTGTGAGGACCCCCCACATGAGCTGCCCCAGGAGGGGAAAGTCCGGACGCCT TGCTGAGTCTGGGCTCTGTCATCGACATTTCAGGCCTGCAACGTGCTGTCAAGGAGGCCCTGTCAGCTGTGCTCCCCCGAGTGGCGGGGC >In-frame_ENST00000321617_ENST00000544570_TCGA-YL-A8SF-01A_CASKIN2_chr17_73509792_-_PDE2A_chr11_72353370_length(amino acids)=258AA_start in transcript=233_stop in transcript=1009 MLSGWALVFHSQAGKIGVPSPSPSWSCRKPQADIHPDFHVAFTPSKISFPSCGGSSRSTFGSIPQYLTRSPLPGTPDLLPRNREPSKGLW HGALTPQLGPVACLCPGLLSVELSPGASMGREQDLILAVKNGDVTGVQKLVAKVKATKTSCCRTCSPKRQSCTSAWPPTVSTGPRCPTSS -------------------------------------------------------------- >In-frame_ENST00000581870_ENST00000376450_TCGA-YL-A8SF-01A_CASKIN2_chr17_73509792_-_PDE2A_chr11_72353370_length(transcript)=3788nt_BP=538nt CGAGCAGGGCCAGCCGGACCCCGGCGGGCGGCCGGGAGAGAGCCCTGAGACCAGTGCACCGCTGCTGCCTGAGGCCCAAGGGAATGCTGG CTGCTCTCTGGGTGGGCACTGGTGTTCCACAGCCAAGCCGGGAAGATTGGTGTGCCCAGTCCCAGCCCATCCTGGAGCTGTCGGAAGCCA CAAGCTGATATCCATCCAGATTTCCATGTAGCCTTCACCCCCTCAAAGATTAGCTTTCCTTCGTGTGGTGGCAGTTCACGGAGCACCTTT GGGAGTATCCCTCAGTACCTGACGAGGAGCCCACTGCCTGGGACACCTGACTTGCTCCCCCGGAACCGGGAGCCCTCCAAGGGGCTGTGG CATGGCGCCCTGACGCCCCAGCTTGGACCCGTTGCCTGCCTTTGCCCTGGACTCCTGAGTGTAGAGCTCAGCCCAGGAGCCAGTATGGGT CGTGAACAGGACCTGATCCTCGCCGTCAAGAATGGAGATGTGACCGGTGTGCAGAAACTGGTGGCGAAGGTCAAGGCCACAAAGACAAGC TGTTGCAGGACCTGTTCCCCAAAGCGGCAGAGCTGTACGAGCGCGTGGCCTCCAACCGTGAGCACTGGACCAAGGTGTCCCACAAGTTCA CCATCCGCGGCCTCCCAAGTAACAACTCGCTGGACTTCCTGGATGAGGAGTACGAGGTGCCTGATCTGGATGGCACTAGGGCCCCCATCA ATGGCTGCTGCAGCCTTGATGCTGAGTGATCCCCTCCAGGGACACTTCCCTGCCCAGGCCACCTCCCACAGCCCTCCACTGGTCTGGCCA GATGCACTGGGAACAGAGCCACGGGTCCTGGGTCCTAGACCAGGACTTCCTGTGTGACCCTGGACAAGTACTACCTTCCTGGGCCTCAGC TTTCTCGTCTGTATAATGGAAGCAAGACTTCCAACCTCACGGAGACTTTGTAATTTGTTTTCTGAGAGCACAGGGGTGACCAATGAGCAG TGGGCCCTACTCTGCACCTCTGACCACACCTTGGCAAGTCTTTCCCAAGCCATTCTTTGTCTGAGCAGCTTGATGGTTTCTCCTTGCCCC ATTTCTGCCCCACCAGATCTTTGCTCCTTTCCCTTTGAGGACTCCCACCCTTTGGGGTCTCCAGGATCCTCATGGAAGGGGAAGGTGAGA CATCTGAGTGAGCAGAGTGTGGCATCTTGGAAACAGTCCTTAGTTCTGTGGGAGGACTAGAAACAGCCGCGGGGCGAAGGCCCCCTGAGG ACCACTACTATACTGATGGTGGGATTGGGACCTGGGGGATACAGGGGCCCCAGGAAGAAGCTGCCAGAGGGGCAGCTCAGTGCTCTGCAG AGAGGGGCCCTGGGGAGAAGCAGGATGGGATTGATGGGCAGGAGGGATCCCCGCACTGGGAGACAGGCCCAGGTATGAATGAGCCAGCCA TGCTTCCTCCTGCCTGTGTGACGCTGGGCGAGTCTCTTCCCCTGTCTGGGCCAAACAGGGAGCGGGTAAGACAATCCATGCTCTAAGATC CATTTTAGATCAATGTCTAAAATAGCTCTATCGCTCTGCGGAGTCCCAGCAGAGGCTATGGAATGTTTCTGCAACCCTAAGGCACAGAGA GCCCAACCCTGAGTGTCTCAGAGGCCCCCTGAGTGTTCCCCTTGGCCTGAGCCCCTTACCCATTCCTGCAGCCAGTGAGAGACCTGGCCT CAGCCCTGGCAGGGCTCTCTCTTCAAGGCCATATCCACCTGTGCCCTGGGGCTTGGGAGACCCCATAGGGCCGGGACTCTTGGGTCAGCC CGGCCACTGGCTTCTCTCTTTTTCTCTGTTTCATTCTGTGTGCGTTGTGGGGTGGGGGAGGGGGTCCACCTGCCTTACCTTTCTGAGTTG CCTTTAGAGAGATGCGTTTTTCTAGGACTCTGTGCAACTGTCGTATATGGTCCCGTGGGCTGACCGCTTTGTACATGAGAATAAATCTAT TTCTTTCTACCGAGAAGGCCATGGGCAACAGGCCGATGGAGATGATGGACCGGGAGAAGGCCTATATCCCTGAGCTGCAAATCAGCTTCA TGGAGCACATTGCAATGCCCATCTACAAGAGCTGATCTACAAAGAATTCTTCTCCCAGGGAGACCTGTGGGCTACGACCGAAACAACAAG CAGCACCACAGACTTCTCCTCTGCCTCCTCATGACCTCCTGTGACCTCTCTGACCAGACCAAGGGCTGGAAGACTACGAGAAAGATCGCG GACTATCAGCGCATGCTGGATCTGATGCGGGACATCATCTTGGCCACAGACCTGGCCCACCATCTCCGCATCTTCAAGGACCTCCAGAAG ATGGCTGAGGAGGCACCACTTTGCTCAGGCCATCGCCATCCTCAACACCCACGGCTGCAACATCTTTGATCATTTCTCCCGGAAGAAATC TGTGCTGGCTGCGCTCTACAGCTCTGAGGGCTCCGTCATGGAGGGACATCGAGATCTTTGCCTTGTTTATTTCCTGCATGTGTCATGACC TGGACCACAGAGGCACAAACAACTCTTTCCAGGTGGCCTCGGTTCTGTTTGATGGTGAAGAAGGGCTACCGGGATCCCCCCTACCACAAC TGGATGCACGCCTTTTCTGTCTCCCACTTCTGCTACCTGCTCTACAAGAACCTGGAGCTCACCAACTACCTCGAGCCATCCTGAGCATGC TGCAGGACATGAATTTCATCAACAACTACAAAATTGACTGCCCGACCCTGGCCCGGTCTCCGATGATGAGTATACCAAACTTCTCCATGA TGGGATCCAGCCTGTGGCTGCCATTGACTCCAATTTTGCAAGTTTCACCTATACCCCTCGTTCCCTGCCCGAGGATGACACGTCCATGTC TCTCCTATACAAAAAAGTGAATGAGGCTCAGTATCGCAGCCACCTGGCCAATGAGATGATGATGTACCACATGAAGAGGTCATCGGTGTG GCCGAGCTGGTGAACAAGATCAATGGGCCATGGTTCAGCAAGTTCGACGAGGACCTGGCGACGGCCTTCTCCATCTACTGCGGCATCAGC ATCGCCCATAGCTATGAGATCCGCATCCCGGCCGATCAGGGCATCGCGGGACACGTGGCGACCACGGGCCAGATCCTGAACATCCCTGAC GCATATGCCCATCCGCTTTTCTACCGCGGCGTGGACGACAGCACCGGCTTCCGCACGCGCAACATCCTCTGCTTCCCCATCAAGAACGAG AACCAGGCTGCTCTGTGTTCCTGCTGGATCAGAATGAGCTGGTGGCCAAGGTGTTCGACGGGGGCGTGGTGGATGATGAGATGACGTCTC TGTCCTGCTCCAGGAGATCATCACGGAGGCCAGAAACCTCAGCAACGCAGAGATGCTCTTCTCCAAGTGGCAAAGAACCTCTTCACCCAC CTGGGTTCACCGACGAGGACGAGCATGTGATCCAGCACTGCTTCCACTACACCAGCACCGTGCTCACCAGCACCCTGGCCTTCCAGAAGG AACAGAAACTCAAGTGTGAGTGCCAGGAAACTGTCTACACCTACCTACTGGATGGTGAGTCCCAGCTGGTGTGTGAGGACCCCCCACATG AGCTGCCCCAGGAGGGGAAAGTCCGGACGCCTTGCTGAGTCTGGGCTCTGTCATCGACATTTCAGGCCTGCAACGTGCTGTCAAGGAGGC CCTGTCAGCTGTGCTCCCCCGAGTGGCGGGGCCAGCAGGTCTTCCTCAAGCCGGACGAGCCGCCGCCGCCGCCGCAGCCATGCGCCGACA >In-frame_ENST00000581870_ENST00000376450_TCGA-YL-A8SF-01A_CASKIN2_chr17_73509792_-_PDE2A_chr11_72353370_length(amino acids)=266AA_start in transcript=1081_stop in transcript=281 MGQGETIKLLRQRMAWERLAKVWSEVQSRAHCSLVTPVLSENKLQSLREVGSLASIIQTRKLRPRKVVLVQGHTGSPGLGPRTRGSVPSA SGQTSGGLWEVAWAGKCPWRGSLSIKAAAAIDGGPSAIQIRHLVLLIQEVQRVVTWEAADGELVGHLGPVLTVGGHALVQLCRFGEQVLQ -------------------------------------------------------------- >In-frame_ENST00000581870_ENST00000544570_TCGA-YL-A8SF-01A_CASKIN2_chr17_73509792_-_PDE2A_chr11_72353370_length(transcript)=3523nt_BP=538nt CGAGCAGGGCCAGCCGGACCCCGGCGGGCGGCCGGGAGAGAGCCCTGAGACCAGTGCACCGCTGCTGCCTGAGGCCCAAGGGAATGCTGG CTGCTCTCTGGGTGGGCACTGGTGTTCCACAGCCAAGCCGGGAAGATTGGTGTGCCCAGTCCCAGCCCATCCTGGAGCTGTCGGAAGCCA CAAGCTGATATCCATCCAGATTTCCATGTAGCCTTCACCCCCTCAAAGATTAGCTTTCCTTCGTGTGGTGGCAGTTCACGGAGCACCTTT GGGAGTATCCCTCAGTACCTGACGAGGAGCCCACTGCCTGGGACACCTGACTTGCTCCCCCGGAACCGGGAGCCCTCCAAGGGGCTGTGG CATGGCGCCCTGACGCCCCAGCTTGGACCCGTTGCCTGCCTTTGCCCTGGACTCCTGAGTGTAGAGCTCAGCCCAGGAGCCAGTATGGGT CGTGAACAGGACCTGATCCTCGCCGTCAAGAATGGAGATGTGACCGGTGTGCAGAAACTGGTGGCGAAGGTCAAGGCCACAAAGACAAGC TGTTGCAGGACCTGTTCCCCAAAGCGGCAGAGCTGTACGAGCGCGTGGCCTCCAACCGTGAGCACTGGACCAAGGTGTCCCACAAGTTCA CCATCCGCGGCCTCCCAAGTAACAACTCGCTGGACTTCCTGGATGAGGAGTACGAGGTGCCTGATCTGGATGGCACTAGGGCCCCCATCA ATGGCTGCTGCAGCCTTGATGCTGAGTGATCCCCTCCAGGGACACTTCCCTGCCCAGGCCACCTCCCACAGCCCTCCACTGGTCTGGCCA GATGCACTGGGAACAGAGCCACGGGTCCTGGGTCCTAGACCAGGACTTCCTGTGTGACCCTGGACAAGTACTACCTTCCTGGGCCTCAGC TTTCTCGTCTGTATAATGGAAGCAAGACTTCCAACCTCACGGAGACTTTGTAATTTGTTTTCTGAGAGCACAGGGGTGAGAGAAGGCCAT GGGCAACAGGCCGATGGAGATGATGGACCGGGAGAAGGCCTATATCCCTGAGCTGCAAATCAGCTTCATGGAGCACATTGCAATGCCCAT CTACAAGAGCTGATCTACAAAGAATTCTTCTCCCAGGGAGACCTGTGGGCTACGACCGAAACAACAAGCAGCACCACAGACTTCTCCTCT GCCTCCTCATGACCTCCTGTGACCTCTCTGACCAGACCAAGGGCTGGAAGACTACGAGAAAGATCGCGGACTATCAGCGCATGCTGGATC TGATGCGGGACATCATCTTGGCCACAGACCTGGCCCACCATCTCCGCATCTTCAAGGACCTCCAGAAGATGGCTGAGGAGGCACCACTTT GCTCAGGCCATCGCCATCCTCAACACCCACGGCTGCAACATCTTTGATCATTTCTCCCGGAAGAAATCTGTGCTGGCTGCGCTCTACAGC TCTGAGGGCTCCGTCATGGAGGGACATCGAGATCTTTGCCTTGTTTATTTCCTGCATGTGTCATGACCTGGACCACAGAGGCACAAACAA CTCTTTCCAGGTGGCCTCGGTTCTGTTTGATGGTGAAGAAGGGCTACCGGGATCCCCCCTACCACAACTGGATGCACGCCTTTTCTGTCT CCCACTTCTGCTACCTGCTCTACAAGAACCTGGAGCTCACCAACTACCTCGAGCCATCCTGAGCATGCTGCAGGACATGAATTTCATCAA CAACTACAAAATTGACTGCCCGACCCTGGCCCGGTCTCCGATGATGAGTATACCAAACTTCTCCATGATGGGATCCAGCCTGTGGCTGCC ATTGACTCCAATTTTGCAAGTTTCACCTATACCCCTCGTTCCCTGCCCGAGGATGACACGTCCATGTCTCTCCTATACAAAAAAGTGAAT GAGGCTCAGTATCGCAGCCACCTGGCCAATGAGATGATGATGTACCACATGAAGAGGTCATCGGTGTGGCCGAGCTGGTGAACAAGATCA ATGGGCCATGGTTCAGCAAGTTCGACGAGGACCTGGCGACGGCCTTCTCCATCTACTGCGGCATCAGCATCGCCCATAGCTATGAGATCC GCATCCCGGCCGATCAGGGCATCGCGGGACACGTGGCGACCACGGGCCAGATCCTGAACATCCCTGACGCATATGCCCATCCGCTTTTCT ACCGCGGCGTGGACGACAGCACCGGCTTCCGCACGCGCAACATCCTCTGCTTCCCCATCAAGAACGAGAACCAGGCTGCTCTGTGTTCCT GCTGGATCAGAATGAGCTGGTGGCCAAGGTGTTCGACGGGGGCGTGGTGGATGATGAGATGACGTCTCTGTCCTGCTCCAGGAGATCATC ACGGAGGCCAGAAACCTCAGCAACGCAGAGATGCTCTTCTCCAAGTGGCAAAGAACCTCTTCACCCACCTGGGTTCACCGACGAGGACGA GCATGTGATCCAGCACTGCTTCCACTACACCAGCACCGTGCTCACCAGCACCCTGGCCTTCCAGAAGGAACAGAAACTCAAGTGTGAGTG CCAGGAGGATGTACAACAGCTGCAGAGCATGTTGGGCTGTGAGCTGCAGGCCATGCTCTGTGTCCCTGTCATCAGCCGGGCCACTGACCA GGTGGTGGCCTTGGCCTGCGCCTTCAACAAGCTAGAAGGAGACTTTTGACAGGATGCCTGGGCCAGGTGGTGGAAGACAAGAAGTCCATC CAGCTGAAGGACCTCACCTCCGTCATCGGAGACAAAGTGCTCGGGGAAGAGGTCAGCTTTCCCCTGCAGCAGGAGACCCGGGCATCCCGC TGCTGCCTCCTGCTGGTGTCGGAGGACAATCTCCAGCTTTCTTGCAAGGGGAACTCTACGACCTGGATGCCTCTTCCCTGCAGCTCAAAG TGCTCCAATACACCCTGGTCGCCCTGCGGAGGGTGCAGGTCCTGCAGCAGCGCGGGCCCAGGGAGGCTCCCCGAGCCGTCCAGAACCCCC CGGAGGGGACGGCGGAAGACCAGAAGGGCGGGGCGGCGTACACCGACCGCGACCGCAAGATCCTCCAACTGTGCGGTGCACTGTGGCCAG CTGAGTGATAATGAGGAATGGAGCCTGCAGGCGGTGGAGAAGCATTGCTGGTCATGCCGCTAGCGGACAAGGAGGCTGGGGCCGTGGCAG CTGTCATCTTGGGAGGCTATCATCTCCCAGAAGCGGCTGGGCTGCAATGGGCTGGGCTTCTCAGACCTGCCAGGGAAGCCCTTGGCCAGG CTGGTGGCTCCACTGGCTCCTGATACCCAAGGAAACTGTCTACACCTACCTACTGGATGGTGAGTCCCAGCTGGTGTGTGAGGACCCCCC ACATGAGCTGCCCCAGGAGGGGAAAGTCCGGACGCCTTGCTGAGTCTGGGCTCTGTCATCGACATTTCAGGCCTGCAACGTGCTGTCAAG GAGGCCCTGTCAGCTGTGCTCCCCCGAGTGGCGGGGCCAGCAGGTCTTCCTCAAGCCGGACGAGCCGCCGCCGCCGCCGCAGCCATGCGC >In-frame_ENST00000581870_ENST00000544570_TCGA-YL-A8SF-01A_CASKIN2_chr17_73509792_-_PDE2A_chr11_72353370_length(amino acids)=258AA_start in transcript=90_stop in transcript=866 MLSGWALVFHSQAGKIGVPSPSPSWSCRKPQADIHPDFHVAFTPSKISFPSCGGSSRSTFGSIPQYLTRSPLPGTPDLLPRNREPSKGLW HGALTPQLGPVACLCPGLLSVELSPGASMGREQDLILAVKNGDVTGVQKLVAKVKATKTSCCRTCSPKRQSCTSAWPPTVSTGPRCPTSS -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for CASKIN2-PDE2A |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CASKIN2-PDE2A |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CASKIN2-PDE2A |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | PDE2A | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
Tgene | PDE2A | C0678222 | Breast Carcinoma | 1 | CTD_human |
Tgene | PDE2A | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
Tgene | PDE2A | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Tgene | PDE2A | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |